Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Respiratory Syncyctial Virus Vaccines

Treatments: Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01706302

116357

Details and patient eligibility

About

The study will assess the burden of RSV-attributable general practice consultations, hosptializations, and deaths by age and risk group in in United Kingdom from 1995 to 2009.

Full description

This epidemiological study is based on an already existing database of time series regression modeling outputs generated during the generated by EPI-FLU-018 BOD UK DB (116273) study, which estimated the burden of influenza in terms of General Practitioner (GP) consultations, hospitalizations, and deaths associated with various respiratory and non-respiratory outcomes.

Enrollment: 1 patient

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Included in the EPI-FLU-018 BOD UK DB BOD UK DB (eTrack: 116273) study database. The inclusion criterion for EPI-FLU-018 was registration with an acceptable flag in the CPRD, or registration in the HES database or the ONS mortality data with a flu-related event.

Exclusion criteria

• Not Applicable

Trial design

1 participants in 1 patient group

Cohort Group

Treatment:

Other: Data collection